
We make clinical trial participation easier for patients, wherever they are and whatever their needs. From personalised support and in-home care to seamless travel, logistics, staffing, and technology, our end-to-end services are designed around real lives, not rigid protocols.
When patients feel valued, supported, and engaged, they’re more likely to stay in the trial, leading to higher retention, stronger recruitment, and better outcomes for everyone involved.
Powered by next-generation care management tools and technologies, our solutions are designed to achieve the four cornerstones of clinical trial success: recruitment, engagement, retention, and trial outcomes.
Everything your trial needs, unique in one partner.
We partner with CROs, sponsors, and sites to deliver patient-first clinical trial solutions that enhance engagement, boost retention, and ease operational burdens.
Whether you’re running a decentralised, hybrid, or traditional trial, our global team and in-house technology platform ensure every interaction is expertly coordinated, fully compliant, and genuinely impactful.
Remarkable experiences, real-world results.
We believe remarkable clinical trials begin with remarkable patient experiences. Our reputation is built on our teams’ ability to solve complex challenges with empathy and expertise. We go above and beyond to keep patients engaged, informed, and supported throughout their clinical trial journey.
From in-home care to global logistics, our personalised services are designed to reduce site burden and operational complexity. The result? Higher retention, stronger engagement, and more reliable data, driving better outcomes for patients and trial sponsors alike.
The company divisions within mdgroup are:
Testimonials
From your team to your patients, we ensure everyone involved in the trial feels supported and valued at every stage of the clinical journey. Here’s what some of our clients say about working with us.
“We have had a wonderful experience with mdgroup’s patientprimary service. As a small pharmaceutical company focusing on rare pediatric diseases, we have very specific (and frequently changing) needs for the families participating in our clinical trials. The patientprimary team has been a tremendous help coordinating payments for families in multiple languages and countries, helping us to seamlessly navigate the many challenges of a multinational trial with a special needs population.”
“mdgroup’s patientprimary service has helped support our study overcome one of the biggest barriers to clinical trial recruitment: patient engagement. By supporting our patients, their parents and carers throughout their clinical trial journey, patientprimary has made the patient and the whole family experience smoother. We would highly recommend this white-glove concierge patient service. The dedicated patientprimary team offers high-end liaison with patients and parents booking their travel, accommodation and rapid reimbursement service. Our patients feel supported and encouraged to attend hospital visits.”
“Thank you to mdgroup’s patientprimary team for your dedicated support in this trial, it really has been beneficial for us to know you are taking such good care of all the travel and reimbursement arrangements. Your concierge service provides multiple advantages for patients and their families, from tailored travel services to fast reimbursement including the arrangements of home nursing visits too. Some of our younger patients benefited from having a research nurse at their doorstep to have simple tasks such as blood drawing performed in an environment they are familiar with.”
Resources
Explore the mdgroup resource centre for the latest developments in technological innovation, decentralised clinical trials, and patient experience.


The 5 Biggest Challenges in Decentralized Clinical Trials and How to Overcome Them
Posted | April 7, 2025
Why Patient-Centricity is the Future of Clinical Trials
Posted | March 26, 2025
Maximising Patient Retention in Central Nervous System Clinical Studies
Posted | March 19, 2025
Advocacy, Empathy, and Support for Rare Disease Patients in Clinical Trials
Posted | February 24, 2025